Health Condition 1: J454- Moderate persistent asthma
Conditions
Interventions
Intervention1: Budesonide + Formoterol: Group A
Budesonide Formoterol 100 mcg plus 6 mcg
Two puffs twice daily
Route Inhalation
Duration 12 weeks
Control Intervention1: Salmeterol + Fluticasone: Group
Sponsors
Shri Sathya Sai Medical College and Research Institute
Eligibility
Inclusion criteria
Inclusion criteria: Children diagnosed with bronchial asthma Age group according to your protocol Patients attending pediatric OPD and IPD Patients whose parents guardians provide informed consent
Exclusion criteria
Exclusion criteria: Children with severe systemic illness Known hypersensitivity to study drugs Children with other chronic respiratory disorders Patients unwilling to participate Poor treatment compliance or inability to follow up
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1Improvement in asthma control among children receiving Budesonide Formoterol versus Salmeterol Fluticasone therapy Timepoint: Baseline and after 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| 1Improvement in pulmonary function tests such as PEFR/FEV1 2Reduction in frequency of acute asthma exacerbations 3Reduction in use of rescue medications 4Assessment of adverse drug reactions and tolerability 5Improvement in symptom score and quality of life Timepoint: 1Baseline and after 3 months 2During follow up period 3Baseline and after 3 months 4Throughout study period 5Baseline and after 3 months | — |
Countries
India
Contacts
Public ContactDr Gonuguntla Divya Vani
Shri Sathya Sai Medical College and Research Institute
Outcome results
None listed